Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Establishment Labs Holdings (ESTA) Cash & Equivalents (2022 - 2025)

Historic Cash & Equivalents for Establishment Labs Holdings (ESTA) over the last 4 years, with Q3 2025 value amounting to $70.6 million.

  • Establishment Labs Holdings' Cash & Equivalents changed N/A to $70.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $70.6 million, marking a year-over-year change of. This contributed to the annual value of $90.3 million for FY2024, which is 12567.0% up from last year.
  • According to the latest figures from Q3 2025, Establishment Labs Holdings' Cash & Equivalents is $70.6 million.
  • Establishment Labs Holdings' Cash & Equivalents' 5-year high stood at $90.3 million during Q4 2024, with a 5-year trough of $40.0 million in Q4 2023.
  • Moreover, its 4-year median value for Cash & Equivalents was $67.8 million (2022), whereas its average is $65.2 million.
  • In the last 5 years, Establishment Labs Holdings' Cash & Equivalents tumbled by 3966.54% in 2023 and then skyrocketed by 12567.0% in 2024.
  • Quarter analysis of 4 years shows Establishment Labs Holdings' Cash & Equivalents stood at $66.4 million in 2022, then tumbled by 39.67% to $40.0 million in 2023, then skyrocketed by 125.67% to $90.3 million in 2024, then fell by 21.83% to $70.6 million in 2025.
  • Its Cash & Equivalents was $70.6 million in Q3 2025, compared to $54.6 million in Q2 2025 and $69.2 million in Q1 2025.